Shirish M Gadgeel (Shirish Gadgeel)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 38

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Ejection Fraction

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer discovery

Antimicrobial stewardship & healthcare epidemiology : ASHE

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Afshin Dowlati, Horst-Dieter Hummel, Stephane Champiat, Maria Eugenia Olmedo, Michael J Boyer, Kai He, Neeltje Steeghs, Hiroki Izumi, Melissa Lynne Johnson, Tatsuya Yoshida, Hasna Bouchaab, Hossein Borghaei, Enriqueta Felip Font, Philipp J Jost, Shirish M Gadgeel, Xi Chen, Youfei Yu, Pablo Martinez, Amanda Parkes, Luis G Paz-Ares
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Rona Yaeger, Meredith A McKean, Rizwan Haq, J Thaddeus Beck, Matthew H Taylor, Jonathan Eliezer Cohen, Daniel W Bowles, Shirish M Gadgeel, Catalin Mihalcioiu, Kyriakos P Papadopoulos, Eli L Diamond, Keren B Sturtz, Gang Feng, Stefanie K Drescher, Micaela B Reddy, Bhaswati Sengupta, Arnab Kumar Maity, Suzy A Brown, Anurag Singh, Eric N Brown, Brian R Baer, Jim Wong, Tung-Chung Mou, Wen-I Wu, Dean R Kahn, Sunyana Gadal, Neal X Rosen, John J Gaudino, Patrice A Lee, Dylan P Hartley, S Michael Rothenberg
A next-generation BRAF inhibitor overcomes resistance to BRAF inhibition in patients with BRAF-mutant cancers using pharmacokinetics-informed dose escalation. Cancer discovery (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Luis G Paz-Ares, Stephane Champiat, W Victoria Lai, Hiroki Izumi, Ramaswamy Govindan, Michael J Boyer, Horst-Dieter Hummel, Hossein Borghaei, Melissa Lynne Johnson, Neeltje Steeghs, Fiona Blackhall, Afshin Dowlati, Noemí Reguart, Tatsuya Yoshida, Kai He, Shirish M Gadgeel, Enriqueta Felip Font, Yiran Zhang, Amrita Pati, Mukul Minocha, Sujoy Mukherjee, Amanda Goldrick, Dirk Nagorsen, Nooshin Hashemi Sadraei, Taofeek Kunle Owonikoko
Tarlatamab, a First-In-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small Cell Lung Cancer: An Open-Label, Phase I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jitender Monga, Frederick Valeriote, Clara Hwang, Shirish M Gadgeel, Jagadananda Ghosh
Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer Cells. Molecular cancer therapeutics 22 (3) (2023)
Tiffany A Ho, Katelyn M Patterson, Shirish M Gadgeel, Rachel M Kenney, Michael P Veve
Cancer is chronic but antimicrobial stewardship is iconic: A retrospective cohort of optimal antibiotic use in ambulatory oncology clinics. Antimicrobial stewardship & healthcare epidemiology : ASHE 3 (1) (2023)
Matthew R Trendowski, Christine M Lusk, Angela S Wenzlaff, Christine M Neslund-Dudas, Shirish M Gadgeel, Ayman O Soubani, Kendra L Schwartz
Assessing a Polygenic Risk Score for Lung Cancer Susceptibility in Non-Hispanic White and Black Populations. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Alexander E Drilon, Joshua C Horan, Anupong Tangpeerachaikul, Benjamin Besse, Sai-Hong Ignatius Ou, Shirish M Gadgeel, D Ross Camidge, Anthonie J van der Wekken, Linh Nguyen-Phuong, Adam Acker, Clare Keddy, Katelyn S Nicholson, Satoshi Yoda, Scot Mente, Yuting Sun, John R Soglia, Nancy E Kohl, James R Porter, Matthew D Shair, Viola W Zhu, Monika A Davare, Aaron N Hata, Henry E Pelish, Jessica J Lin
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations. Cancer discovery 13 (3) (2023)
Luis G Paz-Ares, Stephane Champiat, W Victoria Lai, Hiroki Izumi, Ramaswamy Govindan, Michael J Boyer, Horst-Dieter Hummel, Hossein Borghaei, Melissa Lynne Johnson, Neeltje Steeghs, Fiona Blackhall, Afshin Dowlati, Noemí Reguart, Tatsuya Yoshida, Kai He, Shirish M Gadgeel, Enriqueta Felip Font, Yiran Zhang, Amrita Pati, Mukul Minocha, Sujoy Mukherjee, Amanda Goldrick, Dirk Nagorsen, Nooshin Hashemi Sadraei, Taofeek Kunle Owonikoko
Tarlatamab, a first-in-class DLL3-targeted bispecific T cell engager, in recurrent small-cell lung cancer: an open-label, phase 1 study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Alexander E Drilon, Manish R Sharma, Melissa Lynne Johnson, Timothy Anthony Yap, Shirish M Gadgeel, Dale Nepert, Gang Feng, Micaela B Reddy, Allison S Harney, Mohamed S A Elsayed, Adam W Cook, Christina E Wong, Ronald J Hinklin, Yutong Jiang, Eric N Brown, Nickolas A Neitzel, Ellen R Laird, Wen-I Wu, Anurag Singh, Ping Wei, Keith A Ching, John J Gaudino, Patrice A Lee, Dylan P Hartley, S Michael Rothenberg
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy. Cancer discovery (2023)
Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, James Moon, Philip C Mack, Gregory J Gerstner, Timothy F Burns, Asma Taj, Wallace L Akerley, Konstantin H Dragnev, Noel Laudi, Mary W Redman, Jhanelle E Gray, David R Gandara, Karen Kelly
Phase II study of docetaxel and trametinib in patients with KRAS mutation positive recurrent non-small cell lung cancer (NSCLC) (SWOG S1507, NCT-02642042). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Alexander E Drilon, Joshua C Horan, Anupong Tangpeerachaikul, Benjamin Besse, Sai-Hong Ignatius Ou, Shirish M Gadgeel, D Ross Camidge, Anthonie J van der Wekken, Linh Nguyen-Phuong, Adam Acker, Clare Keddy, Katelyn S Nicholson, Satoshi Yoda, Scot Mente, Yuting Sun, John R Soglia, Nancy E Kohl, James R Porter, Matthew D Shair, Viola W Zhu, Monika A Davare, Aaron N Hata, Henry E Pelish, Jessica J Lin
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations. Cancer discovery 13 (3) (2023)
Alexander E Drilon, Joshua C Horan, Anupong Tangpeerachaikul, Benjamin Besse, Sai-Hong Ignatius Ou, Shirish M Gadgeel, D Ross Camidge, Anthonie J van der Wekken, Linh Nguyen-Phuong, Adam Acker, Clare Keddy, Katelyn S Nicholson, Satoshi Yoda, Scot Mente, Yuting Sun, John R Soglia, Nancy E Kohl, James R Porter, Matthew D Shair, Viola W Zhu, Monika A Davare, Aaron N Hata, Henry E Pelish, Jessica J Lin
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations. Cancer discovery 13 (3) (2023)
Jitender Monga, Frederick Valeriote, Clara Hwang, Shirish M Gadgeel, Jagadananda Ghosh
Daclatasvir, an antiviral drug, downregulates Tribbles 2 pseudokinase and re-sensitizes enzalutamide resistant prostate cancer cells. Molecular cancer therapeutics (2023)
Marcelo Vailati Negrão, Alexander I Spira, Rebecca S Heist, Pasi A Janne, Jose M Pacheco, Jared Weiss, Shirish M Gadgeel, Karen Velastegui, Wenjing Yang, Hirak Der-Torossian, James G Christensen, Joshua K Sabari
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRAS G12C -Mutated Non-Small-Cell Lung Cancer Who Have Untreated CNS Metastases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Pin Li, Kaitlyn L O'Shea, Frank M Wolf, Anna B Berry, Shirish M Gadgeel, Amanda Pilling
Race-Associated Genomic Correlates of Therapeutic Response in African American Patients With Non-Small-Cell Lung Cancer. JCO precision oncology 7 (2023)
Tiffany A Ho, Katelyn M Patterson, Shirish M Gadgeel, Rachel M Kenney, Michael P Veve
Cancer is chronic but antimicrobial stewardship is iconic: A retrospective cohort of optimal antibiotic use in ambulatory oncology clinics. Antimicrobial stewardship & healthcare epidemiology : ASHE 3 (1) (2023)
Jitender Monga, Frederick Valeriote, Clara Hwang, Shirish M Gadgeel, Jagadananda Ghosh
Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer Cells. Molecular cancer therapeutics 22 (3) (2023)
Alexander E Drilon, Joshua C Horan, Anupong Tangpeerachaikul, Benjamin Besse, Sai-Hong Ignatius Ou, Shirish M Gadgeel, D Ross Camidge, Anthonie J van der Wekken, Linh Nguyen-Phuong, Adam Acker, Clare Keddy, Katelyn S Nicholson, Satoshi Yoda, Scot Mente, Yuting Sun, John R Soglia, Nancy E Kohl, James R Porter, Matthew D Shair, Viola W Zhu, Monika A Davare, Aaron N Hata, Henry E Pelish, Jessica J Lin
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations. Cancer discovery 13 (3) (2023)
Tiffany A Ho, Katelyn M Patterson, Shirish M Gadgeel, Rachel M Kenney, Michael P Veve
Cancer is chronic but antimicrobial stewardship is iconic: A retrospective cohort of optimal antibiotic use in ambulatory oncology clinics. Antimicrobial stewardship & healthcare epidemiology : ASHE 3 (1) (2023)
Marina-Chiara Garassino, Shirish M Gadgeel, Giovanna Speranza, Enriqueta Felip Font, Emilio Esteban, Manuel Dómine, Maximilian J Hochmair, Steven Francis Powell, Helge G Bischoff, Nir Peled, Francesco Grossi, Ross R Jennens, Martin Reck, Rina Hui, Edward B Garon, Takayasu Kurata, Jhanelle E Gray, Paul Schwarzenberger, Erin Jensen, M Catherine Pietanza, Delvys Rodriguez Abreu
Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Nitin Ohri, Shruti Jolly, Benjamin T Cooper, Rafi Kabarriti, William R Bodner, Jonathan Klein, Chandan Guha, Viswanathan Shankar, Elaine Shum, Joshua K Sabari, Haiying Cheng, Rasim A Gucalp, Enrico Castellucci, Angel Qin, Shirish M Gadgeel, Balazs Halmos
Selective Personalized Radioimmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Alexander E Drilon, Joshua C Horan, Anupong Tangpeerachaikul, Benjamin Besse, Sai-Hong Ignatius Ou, Shirish M Gadgeel, D Ross Camidge, Anthonie J van der Wekken, Linh Nguyen-Phuong, Adam Acker, Clare Keddy, Katelyn S Nicholson, Satoshi Yoda, Scot Mente, Yuting Sun, John R Soglia, Nancy E Kohl, James R Porter, Matthew D Shair, Viola W Zhu, Monika A Davare, Aaron N Hata, Henry E Pelish, Jessica J Lin
NVL-520 is a selective, TRK-sparing, and brain-penetrant inhibitor of ROS1 fusions and secondary resistance mutations. Cancer discovery (2022)
Fawzi Abu Rous, Radhika Gutta, Pin Li, Balazs Halmos, Shirish M Gadgeel
Pembrolizumab in Combination with Chemotherapy in Patients with ERBB2-Mutated Non-Small Cell Lung Cancer. Targeted oncology 17 (2) (2022)
Alexander E Drilon, Joshua C Horan, Anupong Tangpeerachaikul, Benjamin Besse, Sai-Hong Ignatius Ou, Shirish M Gadgeel, D Ross Camidge, Anthonie J van der Wekken, Linh Nguyen-Phuong, Adam Acker, Clare Keddy, Katelyn S Nicholson, Satoshi Yoda, Scot Mente, Yuting Sun, John R Soglia, Nancy E Kohl, James R Porter, Matthew D Shair, Viola W Zhu, Monika A Davare, Aaron N Hata, Henry E Pelish, Jessica J Lin
NVL-520 is a selective, TRK-sparing, and brain-penetrant inhibitor of ROS1 fusions and secondary resistance mutations. Cancer discovery (2022)